Cargando…
Validation of an HPLC–MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical Practice
Ticagrelor is an antiplatelet agent which is extensively metabolized in an active metabolite: AR-C124910XX. Ticagrelor antagonizes P2Y12 receptors, but recently, this effect on the central nervous system has been linked to the development of dyspnea. Ticagrelor-related dyspnea has been linked to per...
Autores principales: | Lagoutte-Renosi, Jennifer, Royer, Bernard, Rabani, Vahideh, Davani, Siamak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827928/ https://www.ncbi.nlm.nih.gov/pubmed/33429903 http://dx.doi.org/10.3390/molecules26020278 |
Ejemplares similares
-
Influence of Antiplatelet Agents on the Lipid Composition of Platelet Plasma Membrane: A Lipidomics Approach with Ticagrelor and Its Active Metabolite
por: Lagoutte-Renosi, Jennifer, et al.
Publicado: (2021) -
Cholesterol-Rich Microdomains Contribute to PAR1 Signaling in Platelets Despite a Weak Localization of the Receptor in These Microdomains
por: Rabani, Vahideh, et al.
Publicado: (2020) -
Development and validation of an HPLC–MS/MS method to determine clopidogrel in human plasma
por: Liu, Gangyi, et al.
Publicado: (2016) -
Determination of Oseltamivir in Human Plasma by HPLC-MS/MS
por: Lakeev, A. P., et al.
Publicado: (2023) -
Development and Validation of an HPLC-MS/MS Method for Rapid Simultaneous Determination of Cefprozil Diastereomers in Human Plasma
por: He, Guodong, et al.
Publicado: (2018)